Long-term forecasts for Abeona Therapeutics project significant revenue expansion potential if Zevaskyn secures widespread hospital integration and market penetration. Analysts emphasize that future performance will rely heavily on manufacturing consistency, successful expansion of the qualified treatment center network, and efficient capital management.